LexaGene Holdings (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has announced the name and look of their new genetic analyzers for rapid pathogen detection. It’s called MiQLab
Regan told Proactive why that name when they plan on having the units available on the market.
Price: 0.85 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to bring news the company has received a purchase order for the MiQLab system from a multinational biotechnology company that generates billions in annual revenue. Regan says this company was looking...
Retail & consumer
Health
Industry & services
Prev article
